In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

Non-alcoholic fatty liver disease (NAFLD) affects nearly 19 crore people in India and about a quarter of the world’s ...

The trials identified no serious adverse effects, and patients tolerated a daily dosage of 1500 mg for 24 weeks.

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...

Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...

Nonalcoholic fatty liver disease (NAFLD ... Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis, and end-stage ...

A study from Massachusetts General Hospital has found that growth hormone may help improve liver health in people with ...

Here, we argue that metabolic dysfunction-associated steatotic liver disease should be considered a non-communicable disease.

Non-alcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver, and there are a number of ...

These organizations can help you educate yourself, spread awareness, and connect with the MASH community to help you better manage your health.